Search All News
The program brings together physicians and nurse practitioners from multiple disciplines to provide care for smokers and ex-smokers who are at high risk for lung cancer and other complications.
Sexual dysfunction is common among female cancer patients but infrequently addressed. Columbia oncologist Christine Chin is working to change that.
Columbia geneticist Wendy Chung reflects on the progress made in cancer genetics and discusses the next frontier of using genetic information to design personalized cancer prevention strategies.
Columbia cancer researchers estimate that 60% of patients in a phase 2 clinical trial will have no sign of their cancer two years after treatment with combination therapy.
- April 11, 2022
Heavy ions could radically improve radiation therapy for cancer treatment, but research is needed to understand how they work. With the aid of a new instrument at Columbia, scientists aim to find out.
- March 30, 2022
The study's findings underscore the importance of identifying different treatments for different subpopulations of glioma patients.
- March 24, 2022
Columbia's Lisa A. Kachnic, MD, a pioneer in radiation oncology, discusses the advancements made in the field of radiotherapy and the innovation to come.
- March 17, 2022
In the future, bacteria may be let loose in the body to seek and destroy cancer cells, but the bacteria need a way to hide from our immune system. Columbia biomedical engineers may have a solution.
- March 17, 2022
In the early days of Columbia's cancer program, several incredible women physicians and scientists made key discoveries in the field.
- March 7, 2022
Having a rapport with kids is a critical part of the job for James Church and other Columbia colorectal surgeons who treat people with hereditary colon cancer.
- March 3, 2022
Lung cancer often spreads to the brain. Columbia scientists have now uncovered a tactic used by metastases to hide in the brain and identified a drug combination that can potentially target them.
- February 22, 2022
By applying artificial intelligence to standard-of-care imaging, Columbia cancer researchers can predict how well immunotherapy will work for patients with melanoma.
- February 4, 2022
A clinical trial led by a Columbia neuro-oncology team suggests that a new type of anti-cancer drug has promise for patients with glioblastoma.